The effect of High intensity interval training on vascular function and structure alterations compared to Continuous Positive Airway Pressure in Obese Adults with Obstructive Sleep Apnea Syndrome with Type 2 Diabetes Mellitus

presidential scholarship, Chiang Mai university0 sites30 target enrollmentAugust 21, 2023

Overview

Phase: Phase 1
Intervention: Not specified
Conditions: Obese adults with obstructive sleep apnea and Type 2 Diabetes Mellitus
Sponsor: presidential scholarship, Chiang Mai university
Enrollment: 30
Status: Recruiting
Last Updated: last year

No summary available.

Registry

who.int

Start Date

August 21, 2023

End Date

December 31, 2023

Last Updated

last year

Study Type

Interventional

Sex

All

Sponsor

presidential scholarship, Chiang Mai university

•1\) Participants with obesity BMI more than or equal to 25 (kg/m2\), according to Asian criteria
•2\) Participants who have no history of other sleep disorders, asthma, and no history of home CPAP use before participating in the study
•3\) Participants who are newly diagnosed to be OSA and OSA\-free, based on the criteria of Hudgel et al.
•4\) Participants who are diagnosed for T2DM based on the American Diabetes Association criteria
•5\) Participants who are free from diabetic nephropathy, diabetic retinopathy, severe diabetic neuropathy, and severe cardiovascular and cerebrovascular diseases
•6\) Participants who are not physically active (less than 1 hr/week) for at least 3 months
•7\) Participants who have not receive nutritional supplements, CPAP, and other exercise programs, which may affect the study results in the previous 3 months

•1\) Participants who have other diseases or illnesses that affect the breathing disorders and vasculature results including cardiovascular disease, liver disease, renal disease, pulmonary disease, peripheral arterial disease, stroke, or transient ischemic attack
•2\) Participants who have used cigarette smoking in the previous 6 months
•3\) Participants who receive medications, which will not involve usual care and may affect vascular function and/ or structure such as hypnotic and sedative medications
•4\) Participants who have fasting blood glucose more than or equal to 13\.9 mmol/L (250 mg/dL), HbA1c more than or equal to 10% (86 mmol/mol)
•5\) Participants who have blood pressure (BP) greater than 180/110 mmHg or greater than 160/110 mmHg for people on antihypertensive medication
•6\) Participants who have triglyceride to HDL\-C ratio more than 3\.9
•7\) Participants who have variations of weight for 5 kg. in three months
•8\) Participants are unable to exercise such as having medical conditions or musculoskeletal injuries that limit exercise ability
•9\) Participants who have contraindications for exercise such as dyspnea at rest, severe hypertension, and acute joint inflammation etc.